ロード中...
Notice of Compliance with Conditions: A Policy in Limbo
Since 1998, the Therapeutic Products Directorate (TPD) has had a policy termed the Notice of Compliance with conditions (NOC/c) in order to allow earlier marketing of promising drugs for serious conditions before the drugs have definitively demonstrated clinical efficacy. Drugs approved under the NO...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Longwoods Publishing
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2585467/ https://ncbi.nlm.nih.gov/pubmed/19305737 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|